IP Verse

A Xanthine Derivative As Dpp 4 Inhibitor For Use In The Treatment Of Sirs And/Or Sepsis - EP2849754

PATENT ANALYSIS

Patent Details

Grant Date: Sep 14, 2022
Company: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Oppositions

More patents of Boehringer Ingelheim International Gmbh

Want to monitor this patent?

Feel free to send us a message here and we will get back to you